|
|
Post by sportsrancho on Mar 12, 2021 17:34:44 GMT -5
Just stop. It doesn’t matter who prescribes Afrezza Mannkind still gets paid.
Whatever we can do we’re willing to help, if we can keep the patient on the drug then that is just more revenue.
|
|
|
|
Post by mannmade on Mar 12, 2021 17:36:10 GMT -5
I am suggesting a partnership that benefits both and mostly helps diabetics. Vdex is a specialist clinic for diabetic care with a great deal of knowledge about Afrezza, maybe even more practical knowledge than Mnkd dare I say... Or at least they can do things mnkd cannot.
|
|
|
|
Post by Charlie on Mar 12, 2021 17:38:42 GMT -5
I have no doubts at all that Mike and Management have given some consideration to that already.
|
|
|
|
Post by falconquest on Mar 12, 2021 17:42:50 GMT -5
I think connecting them to Vdex is a great idea! Even if there is no Vdex in the area they will be able to get them to a doctor in the area and serve as a secondary consultant for docs that aretoo busy. Isn't that up to Mannkind and the decisions made by the company? Doctors may be overwhelmed right now during Covid but they are hungry for business because people haven't been keeping up with their appointments during the pandemic. Your thinking is liken to Mcdonalds making the burger and selling it at Wendy's while Mcdonalds pays for the advertising. Really? Let's give it all away. The confidence you have for management is surprising. and now back to the topic. afrezza.com/meet-afrezza/?gclid=Cj0KCQiA-aGCBhCwARIsAHDl5x9MuVf9agd7UtFMveLvqVOKC3FAeOvonVCygN8OHuYhb52iCNCiQ6oaAqLZEALw_wcB I think we're getting to the heart of the matter. How is a referral to Vdex giving anything away? Please explain it to me. |
|
|
|
Post by Charlie on Mar 12, 2021 17:46:44 GMT -5
LOL. why give it away. Not even worth answering that. Good luck to you!
I will say, he who owns information rules the market. You don't give it away. No CEO in their right mind would give it away.
|
|
|
|
Post by falconquest on Mar 12, 2021 17:51:31 GMT -5
LOL. why give it away. Not even worth answering that. Good luck to you! Exactly what I thought. Make a claim you can't back up. Good day sir! |
|
|
|
Post by cretin11 on Mar 12, 2021 19:23:23 GMT -5
LOL. why give it away. Not even worth answering that. Good luck to you! I will say, he who owns information rules the market. You don't give it away. No CEO in their right mind would give it away. Charlie, your passion is great. However I respectfully submit that your ire is misplaced. As Falcon correctly points out, the VDEX suggestion wouldn’t take anything away from MannKind. But it’s even more than that, here’s the point that surely you can’t dispute: RETENTION If MannKind were to tweak that nice looking ad and direct people to VDEX, then the patient experience would be so much better. The VDEX protocol would maximize the odds of retention by ensuring the patient gets the most out of Afrezza. What we don’t want is patients going to an endo who prescribes Afrezza but doesn’t understand the nuances of dosing, etc. That just gives us a new script that does NOT become a repeat customer. Better retention helps everybody! Yes of course it would help VDEX, but also would help MannKind and let’s not forget the PWDs. |
|
|
|
Post by longliner on Mar 12, 2021 21:05:48 GMT -5
I have no doubts at all that Mike and Management have given some consideration to that already. [br Absolutely they have. Charlie, I suggest if you are a long term investor arguing with folks that hold no position in Mannkind may be a waste of time. |
|
|
|
Post by mango on Mar 12, 2021 21:36:23 GMT -5
Vdex is the result of ADA and FDA’s negligence and incompetence of diabetes care. The SOC is a proven failure—that’s a fact. Vdex had proven to mitigate that failure by implementing a specific treatment option that has been proven both scientifically and in the real world settings to restore glucose homeostasis and be far superior to any other oral or insulin product on the market today.
The day the egos are left at the door is the day we can open it.
|
|
|
|
Post by Charlie on Mar 12, 2021 21:47:16 GMT -5
Vdex is the result of ADA and FDA’s negligence and incompetence of diabetes care. The SOC is a proven failure—that’s a fact. Vdex had proven to mitigate that failure by implementing a specific treatment option that has been proven both scientifically and in the real world settings to restore glucose homeostasis and be far superior to any other oral or insulin product on the market today. The day the egos are left at the door is the day we can open it. we are moving into a new chapter Mango as you know. What is now is different. We are in a new chapter while those who challenge and state smoke and mirrors appear to be upset. I'm surprised to see you give Falcon your support. Do you really want to turn over data to vdex at this point in the game? You surprise me! Re: MNKD and recent funding do you not think that MNKD will be in a better position to market once UTHR drug is approved by the FDA? How far away in time is that. Regardless... your support of giving Vdex a freebee blows me away. it's time for MNKD to take what it has earned and run with it! Sorry we don't agree. |
|
|
|
Post by cretin11 on Mar 12, 2021 22:28:03 GMT -5
Vdex is the result of ADA and FDA’s negligence and incompetence of diabetes care. The SOC is a proven failure—that’s a fact. Vdex had proven to mitigate that failure by implementing a specific treatment option that has been proven both scientifically and in the real world settings to restore glucose homeostasis and be far superior to any other oral or insulin product on the market today. The day the egos are left at the door is the day we can open it. Do you really want to turn over data to vdex at this point in the game? it's time for MNKD to take what it has earned and run with it! 1) Yes. 2) Look at the script count from MNKD running with it alone. |
|
|
|
Post by Charlie on Mar 12, 2021 22:58:26 GMT -5
I have no doubts at all that Mike and Management have given some consideration to that already. [br Absolutely they have. Charlie, I suggest if you are a long term investor arguing with folks that hold no position in Mannkind may be a waste of time. Your Post says it all. Thank You. |
|
|
|
Post by sportsrancho on Mar 12, 2021 23:30:46 GMT -5
Vdex is the result of ADA and FDA’s negligence and incompetence of diabetes care. The SOC is a proven failure—that’s a fact. Vdex had proven to mitigate that failure by implementing a specific treatment option that has been proven both scientifically and in the real world settings to restore glucose homeostasis and be far superior to any other oral or insulin product on the market today. The day the egos are left at the door is the day we can open it. Wow...well said❣️ |
|
|
|
Post by longliner on Mar 13, 2021 1:13:56 GMT -5
Just stop. It doesn’t matter who prescribes Afrezza Mannkind still gets paid. Whatever we can do we’re willing to help, if we can keep the patient on the drug then that is just more revenue. Let's face it, we don't have a very big team pushing Afrezza, period! We need everyone on the team to increase the awareness and use of this product. We may not like or value every teammate....but we need every one of them if we are to be successful. |
|
|
|
Post by falconquest on Mar 13, 2021 9:25:35 GMT -5
I see no point in choosing "sides", that's rather banal to me. I have stated for a long time that Mannkind will not be successful until it can sell Afrezza. Thus far they have been unable to achieve the market penetration we all felt was possible. Until that happens........good luck!
|
|
